Clinical utility of FDG-PET for the clinical diagnosis in MCI.
Javier ArbizuCristina FestariDaniele AltomareZuzana WalkerFemke BouwmanJasmine RivoltaStefania OriniHenryk BarthelFederica AgostaAlexander DrzezgaPeter NestorMarina BoccardiGiovanni Battista FrisoniFlavio Nobilinull nullPublished in: European journal of nuclear medicine and molecular imaging (2018)
FDG-PET has clinical utility on a fair level of evidence in detecting MCI due to AD. Although promising also in detecting MCI due to FTLD and MCI due to DLB, more research is needed to ultimately judge the clinical utility of FDG-PET in these entities.